| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |